Clincosm LogoSign in Get a demo

Coronary Artery Disease

Showing NaN - NaN of 132
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Deep Learning Algorithm for Detecting Obstructive Coronary

Recruiting
  • Coronary Artery Disease
  • Artificial Heart Device User
  • coronary artery imaging (coronary CTA or coronary angiography)
  • Beijing, 北京, China
    Yong Zeng
Oct 22, 2023

Diagnosis of Ischemic Heart Disease Determined by Fraction Flow

Recruiting
  • Coronary Artery Disease
    • Beijing, Beijing, China
      Fuwai Hospital
    Sep 7, 2023

    Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)

    Not yet recruiting
    • Elevated Lipoprotein(a) Level
    • +3 more
    • 24 Months DAPT
    • 12 Months DAPT
    • Beijing, Beijing, China
      Fuwai Hospital, National Center for Cardiovascular Diseases, Chi
    Aug 26, 2023

    Coronary Artery Disease Trial in Beijing (No-touch vein graft, Radial artery graft)

    Not yet recruiting
    • Coronary Artery Disease
    • No-touch vein graft
    • Radial artery graft
    • Beijing, Beijing, China
      Fuwai Hospital Chinese Academay of Medical Science and National
    Aug 23, 2023

    Disease Characteristics of IR-CAD: a Case-control Study

    Not yet recruiting
    • Coronary Artery Disease
    • +6 more
    • Protocol-defined Examinations
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Aug 17, 2023

    Predictors of Postoperative Atrial Fibrillation After CABG

    Active, not recruiting
    • Coronary Artery Disease
    • Atrial Fibrillation New Onset
    • CABG
    • Beijing, China
      Beijing Anzhen Hospital
    Jun 1, 2023

    Coronary Revascularization in Patients On Dialysis in

    Active, not recruiting
    • Coronary Artery Disease
    • +2 more
      • Beijing, Beijing, China
        China-Japan Friendship Hospital
      Apr 23, 2023

      Coronary Artery Disease Trial in Worldwide (Inclisiran sodium 300 mg, Placebo)

      Recruiting
      • Coronary Artery Disease
      • Inclisiran sodium 300 mg
      • Placebo
      • Huntsville, Alabama
      • +54 more
      Jan 31, 2023

      Coronary Artery Disease, Coronary Artery Bypass, Diabetes Trial in Beijing (Smartphone Application)

      Completed
      • Coronary Artery Disease
      • +2 more
      • Smartphone Application
      • Beijing, Beijing, China
        Chinese Academy of Medical Science,Fuwai Hospital
      Jan 18, 2023

      Product Surveillance Registry

      Recruiting
      • Cardiac Rhythm Disorders
      • +14 more
        • Birmingham, Alabama
        • +394 more
        Dec 19, 2022

        Coronary Artery Disease, Myocardial Ischaemia, Coronary Circulation Trial in Beijing (QFR, Angiography)

        Active, not recruiting
        • Coronary Artery Disease
        • +4 more
        • QFR
        • Angiography
        • Beijing, Beijing, China
          Fu Wai Hospital, National Center for Cardiovascular Diseases, Ch
        Dec 16, 2022

        Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy Trial in Beijing (De-escalated Dual

        Recruiting
        • Coronary Artery Disease
        • +6 more
        • De-escalated Dual Antiplatelet Therapy
        • Dual Antiplatelet Therapy
        • Beijing, China
          Fuwai Hospital
        Dec 13, 2022

        Coronary Artery Disease, Intravascular Lithotripsy Trial in China (Intracoronary lithotripsy balloon catheter and Intracoronary

        Not yet recruiting
        • Coronary Artery Disease
        • Intravascular Lithotripsy
        • Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus
        • Dragonfly Opstar Imaging Catheter
        • Guangzhou, Guangdong, China
        • +19 more
        Dec 13, 2022

        Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Beijing (Aspirin + Clopidogrel +

        Not yet recruiting
        • Coronary Artery Disease
        • +2 more
        • Aspirin + Clopidogrel + Rivaroxaban
        • Aspirin + Clopidogrel
        • Beijing, Beijing, China
          Chinese Academy of Medical Sciences, Fuwai Hospital
        Dec 5, 2022

        Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases Trial in Shenyang, Beijing (Resolute Onyx™

        Active, not recruiting
        • Ischemic Heart Disease
        • +4 more
        • Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
        • Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
        • Shenyang, Liaoning, China
        • +1 more
        Nov 2, 2022

        Sensor-equipped Ultrathin Pressure Microcatheter Versus Pressure

        Enrolling by invitation
        • Coronary Artery Disease
        • +2 more
        • Randomized physiological measurements by the two systems
        • Beijing, Beijing, China
        • +10 more
        Oct 30, 2022

        Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome Trial in China (Clopidogrel and Aspirin dual-antiplatelet

        Recruiting
        • Coronary Artery Disease
        • +9 more
        • Clopidogrel and Aspirin dual-antiplatelet therapy
        • Aspirin monotherapy
        • Beijing, Beijing, China
        • +108 more
        Oct 25, 2022

        Stable Chronic Angina, Ischemic Heart Disease, Coronary Artery Disease Trial in Beijing (remote intervention, Routine outpatient

        Recruiting
        • Stable Chronic Angina
        • +4 more
        • remote intervention
        • Routine outpatient follow-up
        • Beijing, Beijing, China
          Fuwai Hospital, Chinese Academy of Medical Science; National Cen
        Oct 20, 2022

        Safety of RuiXin-CoronaryAI for Diagnosis of Coronary Artery

        Recruiting
        • Coronary Artery Disease
        • +3 more
        • RuiXin-CoronaryAI software
        • Beijing, Beijing, China
        • +2 more
        Sep 19, 2022

        Brain-heart Interaction in Coronary Plaque Stability and

        Recruiting
        • Coronary Artery Disease
        • CCTA and 18F-FDG-PET/CT
        • Beijing, China
        • +3 more
        Sep 15, 2022

        Wearable Electrocardiogram in Diagnosis of Coronary Artery

        Active, not recruiting
        • Coronary Artery Disease
        • Wearable electrocardiogram
        • Beijing, Beijing, China
          Hongjian Wang
        Aug 23, 2022

        Cardiovascular Diseases, Coronary Artery Disease, Multidisciplinary Communication Trial in Beijing (heart team meeting and

        Not yet recruiting
        • Cardiovascular Diseases
        • +2 more
        • heart team meeting and discussion
        • Beijing, Beijing, China
          China National Center for Cardiovascular Diseases
        Aug 22, 2022

        Coronary Artery Disease Trial in Beijing (Baseline V-RESOLVE score-guided PCI, Angiography-guided PCI)

        Not yet recruiting
        • Coronary Artery Disease
        • Baseline V-RESOLVE score-guided PCI
        • Angiography-guided PCI
        • Beijing, Beijing, China
          Fuwai Hospital
        Aug 14, 2022

        Coronary Artery Disease, Arteritis Trial in Beijing (glucocorticoid and immunosuppressants)

        Recruiting
        • Coronary Artery Disease
        • Arteritis
        • glucocorticoid and immunosuppressants
        • Beijing, Beijing, China
          Jia Lei
        Jul 11, 2022

        Coronary Artery Disease, Calcifications Vascular Trial in Beijing (Shockwave Coronary Intravascular Lithotripsy (IVL) System C2)

        Active, not recruiting
        • Coronary Artery Disease
        • Calcifications Vascular
        • Shockwave Coronary Intravascular Lithotripsy (IVL) System C2
        • Beijing, China
        • +2 more
        Jun 21, 2022